Sleep Disorder: Clinical Trials

7 trials for Sleep Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 recruiting. 7 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 5, Not yet recruiting 1, Recruiting 1
Phase 23Completed 2, Recruiting 1

Follow Sleep Disorder: new trials by email Literature Review of Sleep Disorder trials Research Report on Sleep Disorder

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving Sleep in a Psychiatric Hospital
Scented Oil, Ear Plugs, Eye Mask - Sleep Disorder, Mental Health Issue
Phase 1Not yet recruitingThe University of Texas Health Science Center, Houston402025-06-012025-06-08
Improving Perioperative Sleep Disorders
Pregabalin, Zolpidem - Sleep Disorder
Phase 1CompletedMengchang Yang2152024-07-022024-12-30
The Efficacy and Safty of FMT in Patients With CID
fecal microbiota, Placebo, synbiotics - Insomnia Chronic, Fecal Microbiota Transplantation
Phase 1 / Phase 2CompletedPeking University Sixth Hospital802023-10-082026-02-27
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
Drug Lowering Cerebral Blood Flow (CBF) and Normoxia Sleep, Drug Lowering CBF and Intermittent Hypoxia Sleep, Placebo and Normoxia Sleep - Obstructive Sleep Apnea of Adult, Hypoxia, Brain
Phase 1 / Phase 2RecruitingUniversity of Calgary122023-01-012026-05-01
Efficacy and Safety Study of Propofol Infusion for Refractory Chronic Primary Insomnia
propofol injectable emulsion - Insomnia, Sleep Disorder
Phase 1CompletedLife Extension Foundation Inc.22013-06-012016-08-30
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness
ABT-652, Placebo - Sleep Disorder
Phase 1CompletedAbbott362010-08-012011-07-04
Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in Children
Zolpidem - Insomnia, Sleep Disorder
Phase 1 / Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)632002-10-012007-06-29

Narrower conditions

Sleep Wake Disorders (7)  ·  Sleep Initiation and Maintenance Disorders (3)  ·  Sleep Deprivation (2)  ·  Anxiety Disorders (1)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Dyssomnias (1)  ·  Hypoxia, Brain (1)  ·  Sleep Apnea Syndromes (1)  ·  Stroke (1)  ·  Suicidal Ideation (1)

Broader conditions

Mental Disorders (7)  ·  Nervous System Diseases (7)  ·  Neurologic Manifestations (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Signs and Symptoms (7)  ·  Sleep Disorders, Intrinsic (4)  ·  Dyssomnias (3)  ·  Behavior (2)  ·  Behavioral Symptoms (2)  ·  Apnea (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Cognition Disorders (1)

Interventions

Zolpidem (2)  ·  Cerebrovascular Circulation (1)  ·  Core Binding Factors (1)  ·  Ear Protective Devices (1)  ·  Fecal Microbiota Transplantation (1)  ·  Odorants (1)  ·  Pregabalin (1)  ·  Synbiotics (1)

Sponsors

Abbott (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Life Extension Foundation Inc. (1)  ·  Mengchang Yang (1)  ·  Peking University Sixth Hospital (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of Calgary (1)

Countries

United States (4)  ·  China (2)  ·  Canada (1)

Top investigators

Edward A Czinn, M.D. (1)  ·  Jeffrey L. Blumer, Ph.D., M. D. (1)  ·  Michelle Patriquin, PhD, ABPP (1)  ·  Yang Mengchang, Doctor (1)

Results publications

PMID 42026772